Literature search and pre-formulation studies
At HAB Pharma, Research and Development (R&D) is driven by a clear purpose: to translate pharmaceutical science into safe, effective and patient-focused medicines. Our formulation R&D brings together scientific expertise, rigorous development processes and a deep understanding of drug delivery to create formulations built for quality, stability and consistent performance.
From selecting the right formulation and excipients to optimization, analytical evaluation and stability testing, we follow a structured approach to transforming active pharmaceutical ingredients into robust, scalable dosage forms. Every stage is focused on achieving reproducibility, manufacturability and reliable performance throughout the product lifecycle.
With capabilities spanning conventional, complex and specialized formulations, HAB Pharma’s R&D takes products from concept through development and towards commercialization, creating a seamless pathway from scientific innovation to market-ready medicines.
Our multidisciplinary R&D framework encompasses:
Development of robust formulations and seamless transfer to manufacturing.
Establishment and validation of analytical methods to ensure product quality.
Ensuring adherence to quality standards across all development stages.
Supporting innovation through structured IP strategies.
Aligning development with regulatory requirements for successful approvals.
Coordinating cross-functional activities for timely and efficient execution.
We also keep a detailed eye and check if there have been any neglected interactions in between the process of manufacturing to the final delivery of the goods ensuring double safety and high-quality measures.
If a cosmetic enclosure is used, tests are undertaken to check if there is any of a mixture turn adsorbed upon plastic and if any plasticizers, lubricants, pigments or stabilizers leach out of a cosmetic into a preparation.
We make sure to check and test the quality of the adhesives for an enclosure tag as a part of our quality parameters.
Our Process
Literature search and pre-formulation studies
Excipient compatibility studies
Formulation development
Optimization studies
Analytical method validation
Stability studies
Technology transfer to manufacturing
Commercialization of the product
Our R&D capabilities span a wide range of dosage forms, enabling us to address diverse therapeutic and delivery requirements across product categories.
In addition to conventional dosage forms, we possess capabilities in the development of complex and specialized formulations, supporting differentiated and high-value product development. This combination of broad formulation capabilities and advanced expertise enables the development of robust, scalable, and commercially viable pharmaceutical products.
Every stage of the pipeline above is guided by Quality by Design (QbD) principles. Rather than testing quality into a product after the fact, we build it in from the start combining active ingredients with suitable excipients through structured lab-scale trials, so that each formulation is optimized, reproducible, and ready for manufacturing before it ever leaves R&D.
This approach ensures consistency, process control, and a smooth transition from prototype to commercial-scale production.
At HAB Pharma, quality is embedded across the entire R&D lifecycle. From early-stage development and analytical evaluation to documentation and technology transfer, we follow defined protocols, maintain data integrity, and conduct structured technical reviews to ensure consistency, reliability, and compliance.
Our quality framework incorporates stage-wise technical and peer reviews, analytical method validation, comprehensive documentation, and routine equipment calibration and validation.
These measures enable the early identification and resolution of potential deviations, strengthening the robustness of our products before technology transfer to manufacturing.
By integrating quality into development from the outset, HAB Pharma ensures that every product is built on a foundation of scientific rigor, process discipline, and readiness for scale-up and commercialization.
Addressing critical therapeutic areas by combining precision research, advanced biotechnology, and patient-centric healthcare solutions worldwide.

Targeted treatments for fast, effective relief from back, joint, and inflammatory pain.

Comprehensive solutions for heart health, blood pressure control, and cholesterol management.

Advanced formulations to support neurological health, sleep disorders, and mental wellness.

Specialized therapies designed to treat acidity, gut health issues, and gastrointestinal conditions.

Precision medicines for metabolic disorders and long-term blood sugar regulation.

Effective care for asthma, nasal congestion, and pulmonary conditions.

Broad-spectrum antibiotics, antifungals, and anti-infectives to combat diverse bacterial and fungal treatments.

Dermatology formulations including serums, creams, and specialized hair care treatments.

Daily essential vitamins, minerals, and dietary supplements to promote overall wellness.

Dedicated healthcare solutions for reproductive health and urological conditions.
Intellectual property management is an integral part of our product development framework. We follow a structured approach to identifying, evaluating, protecting, and monitoring intellectual property throughout the development lifecycle, with a focus on safeguarding formulation know-how, process innovation, and other proprietary assets.






Protection of confidential information is supported through defined confidentiality protocols and Non-Disclosure Agreements (NDAs) with relevant employees, contractors, customers, vendors, suppliers, and external partners.
Access to sensitive technical and commercial information is appropriately controlled to help safeguard proprietary formulation information, manufacturing processes, development data, and other intellectual property assets.

Intellectual property assets and relevant third-party developments are monitored as part of our broader IP governance framework. Where appropriate, suitable measures are undertaken to protect the Company's intellectual property rights and proprietary information against unauthorized use or potential infringement.
Through this structured approach, intellectual property considerations are incorporated into product development while protecting proprietary knowledge and supporting sustainable innovation.
Our multidisciplinary R&D framework encompasses:
Development of robust formulations and seamless transfer to manufacturing.
Establishment and validation of analytical methods to ensure product quality.
Ensuring adherence to quality standards across all development stages.
Supporting innovation through structured IP strategies.
Aligning development with regulatory requirements for successful approvals.
Coordinating cross-functional activities for timely and efficient execution.